Piperlongumine — Piplartine (Pyridone Alkaloid · Selective Anticancer · GSTP1 Inhibitor)

Compound	Piperlongumine (Piplartine)
Chemical class	Alkaloid — Pyridone (3,4,5-Trimethoxyphenyl tetrahydropyridine amide)
CAS	20069-09-4
Primary source	Piper longum (long pepper / Pippali roots and fruit), Piper nigrum (minor)
Key applications	Selective anticancer (ROS-mediated), anti-inflammatory, GSTP1 inhibition, tumour microenvironment
Claim strength	Emerging
Typical form	Long pepper extract (piperlongumine as minor alkaloid alongside piperine); piperlongumine isolate
Buy from Herbuno	Organic Pippali / Long Pepper (Piper longum) Fruit Powder → Pipali Fruit Liquid Extract (Water Soluble) - Piper longum →

Name origin: From Piper longum (long pepper) + -amine (alkaloid suffix). Also known as piplartine from Piplartia pellucida (a related Piper species). Piperlongumine is an amide alkaloid structurally distinct from piperine — it contains a pyridone ring system (6-membered lactam) rather than piperidine, making it a different alkaloid class despite co-occurring with piperine in Piper species. Traditional use: Long pepper (Piper longum, Pippali in Ayurveda, Bi Bo in TCM) is one of the most important spices in both Ayurvedic and traditional Chinese medicine — used as a digestive stimulant, bioavailability enhancer (alongside black pepper in Trikatu), anti-inflammatory, and for respiratory conditions. Pippali has specific Ayurvedic protocols including Pippali rasayana (progressive Pippali dose escalation for rejuvenation). Piperlongumine contributes to Pippali’s anticancer and anti-inflammatory properties. Research trajectory: Piperlongumine has attracted significant research interest for a specific property: selective toxicity to cancer cells relative to normal cells via glutathione/ROS mechanisms. It inhibits GSTP1 (glutathione S-transferase P1), an enzyme overexpressed in many tumour cells, leading to selective ROS accumulation and cancer cell death while sparing normal cells. This selectivity — if validated in clinical contexts — would represent a pharmacologically novel anticancer mechanism from a dietary spice. Human clinical data are absent; this remains a compelling preclinical lead. Commercial source: Indian Long Pepper Extract (Pippali) from Herbuno co-delivers piperlongumine alongside piperine. See sourcing options below.

---

Evidence for Piperlongumine Applications

Selective cancer cell toxicity — GSTP1/ROS mechanism: The landmark Raj et al. 2011 paper (Nature Chemical Biology) screened ~200,000 compounds for selective cancer cell toxicity; piperlongumine was identified as a top hit. It inhibits GSTP1 (glutathione S-transferase P1, overexpressed in cancer cells) and TRXR1 (thioredoxin reductase), causing ROS accumulation specifically in cancer cells where antioxidant reserve is already stressed — while normal cells with higher antioxidant capacity survive. Subsequent studies confirmed anticancer activity in breast, prostate, colon, pancreatic, glioma, and leukaemia cell lines and multiple animal xenograft models. Claim strength: Emerging (compelling preclinical; Phase I/II trials initiated but no published results yet).

Anti-inflammatory: Piperlongumine inhibits NF-κB and STAT3 pathways — the same dual mechanism that makes it relevant both for inflammation and for cancer (STAT3 is overactivated in many tumours). Consistent with traditional Pippali anti-inflammatory use. Claim strength: Moderate.

Blood glucose modulation: Piperlongumine inhibits aldose reductase and reduces advanced glycation end-products in diabetic animal models — relevant for diabetic complication management alongside piperine’s insulin-sensitising effects in Pippali. Claim strength: Moderate (animal).

---

Dosage & Formulator Specification

No human clinical dose established for piperlongumine. Preclinical anticancer studies use 2.5–10 µM concentrations in cell models and 2–10 mg/kg in animal models. Human equivalent dose extrapolation is not straightforward given the cancer-selective mechanism requires reaching target tissue concentrations. Long pepper extract (Pippali) delivers piperlongumine as a minor alkaloid constituent alongside piperine — request HPLC alkaloid profile specifying both piperine and piperlongumine content on CoA. Piperlongumine content in long pepper: approximately 0.1–0.5% in dried root. For supplement positioning, Pippali extract’s combination of piperine (bioavailability enhancer) and piperlongumine (emerging anticancer interest) provides a scientifically interesting dual-function profile.

---

Frequently Asked Questions — Piperlongumine

What makes piperlongumine selectively toxic to cancer cells?
Cancer cells have elevated basal ROS levels (from oncogene-driven metabolic reprogramming) and rely on antioxidant defences (particularly GSTP1 and thioredoxin) to manage this oxidative stress. Piperlongumine inhibits GSTP1 and TRXR1, removing this antioxidant buffer — pushing cancer cells past the ROS threshold for apoptosis. Normal cells have lower basal ROS and higher antioxidant reserve, so the same GSTP1 inhibition does not push them into apoptosis. This “cancer cell antioxidant dependency” is the exploited vulnerability.

Is piperlongumine in clinical trials?
Piperlongumine has been identified as a clinical candidate and at least one Phase I trial (NCT NCT04678349 and related) has been initiated to evaluate safety and pharmacokinetics. The clinical data are not yet published in peer-reviewed literature. The preclinical pipeline is active with multiple pharmaceutical companies and academic groups developing piperlongumine analogues with improved pharmacokinetic properties for oncology applications.

Is long pepper the same as black pepper?
No. Both are Piper species but botanically different: black pepper is Piper nigrum (small round berries, dried); long pepper is Piper longum (elongated catkin-like fruiting spike). Both contain piperine as the primary alkaloid (piperine content is actually higher in long pepper by some analyses) but piperlongumine is primarily found in long pepper roots and is minor or absent in black pepper. In Ayurveda, long pepper has different therapeutic applications from black pepper.

Can piperlongumine be positioned in an anti-cancer supplement?
Not with cancer treatment claims — no human clinical data exist to support such claims and regulatory frameworks prohibit disease treatment claims for dietary supplements. However, positioning Pippali/long pepper extract within a general antioxidant or cellular health formulation is appropriate, with educational content referencing the emerging research without disease-specific claims. Formulators targeting sophisticated B2B customers can reference the GSTP1 mechanism and Raj et al. preclinical data in technical documentation.

Related compounds: Piperine, Capsaicin, Sulforaphane, Gingerol

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery